[go: up one dir, main page]

JPS5852995B2 - Method for producing furfural derivatives - Google Patents

Method for producing furfural derivatives

Info

Publication number
JPS5852995B2
JPS5852995B2 JP56154483A JP15448381A JPS5852995B2 JP S5852995 B2 JPS5852995 B2 JP S5852995B2 JP 56154483 A JP56154483 A JP 56154483A JP 15448381 A JP15448381 A JP 15448381A JP S5852995 B2 JPS5852995 B2 JP S5852995B2
Authority
JP
Japan
Prior art keywords
general formula
compound
compound represented
reaction
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56154483A
Other languages
Japanese (ja)
Other versions
JPS57145873A (en
Inventor
胖 桑田
紘之 多和田
寛司 目黒
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Priority to JP56154483A priority Critical patent/JPS5852995B2/en
Publication of JPS57145873A publication Critical patent/JPS57145873A/en
Publication of JPS5852995B2 publication Critical patent/JPS5852995B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Description

【発明の詳細な説明】 本発明は医薬品などとして有用な一般式 (式中、R1はニトロ基を、Xは酸素原子を示す)で表
わされる化合物(I)の合成中間体として用いられれる
一般式 (式中、R’ 、 R2,Xは前記と同意義を有する)
で表わされる新規化合物の製造法に関するものである。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a general compound used as a synthetic intermediate for the compound (I) represented by the general formula (in the formula, R1 represents a nitro group and X represents an oxygen atom) and is useful as a pharmaceutical product. Formula (wherein R', R2, and X have the same meanings as above)
This invention relates to a method for producing a novel compound represented by:

上記一般式(I)で表わされる化合物は筋弛緩作用を有
する薬剤としてきわめて有効であり、その製造法として
アメリガ特許43415821(1968年)記載の方
法があるが、その製法は一般に収率が悪く工業的に有利
な方法とはいい難い。
The compound represented by the above general formula (I) is extremely effective as a drug having muscle relaxing effects, and its manufacturing method includes the method described in Ameriga Patent No. 4,341,5821 (1968), but this manufacturing method generally has poor yields and is not suitable for industrial use. It is difficult to say that this method is economically advantageous.

本発明者等は、種々検討の結果、一般式 (式中、R1は前記と同意義を有する)で表わされる化
合物と一般式 %式% () (式中、R2は低級アノ+4yし基を示し、Xは前記と
同意義を有する)で表わされる化合物を反応させるか、
または化合物(II)と一般式 %式%() (式中、R2は前記と同意義を有する)で表わされる化
合物を反応させて一般式 (式中、R1、R2は前記と同意義を有する)で表わさ
れる化合物とし、ついでイソシアン酸を反応させること
によって得られる化合物(ト)を加熱環化させると、化
合物(I)が高収率で製造し得ることを見出し、これに
基づいて本発明を完成した。
As a result of various studies, the present inventors have discovered a compound represented by the general formula (wherein R1 has the same meaning as above) and a compound represented by the general formula %formula% () (wherein R2 is a lower ano+4y group). and X has the same meaning as above) is reacted, or
Alternatively, compound (II) is reacted with a compound represented by the general formula % (in which R2 has the same meaning as above), and ) was found to be able to be produced in high yield by heating and cyclizing compound (g) obtained by reacting isocyanic acid with isocyanic acid.Based on this, the present invention completed.

即ち、本発明は、 (1)化合物(n)と化合物(l[)を反応させること
を特徴とする、化合物(ト)の製造法、 (2)化合物(n)とヒドラジノ酢酸エステル類(イ)
を反応させて化合物(V)を製造し、これにイソシアン
酸を反応させることを特徴とする、化合物(ト)の製造
法に関するものである。
That is, the present invention provides (1) a method for producing compound (g), characterized by reacting compound (n) and compound (l[); )
The present invention relates to a method for producing compound (g), which is characterized by reacting compound (V) with isocyanic acid.

本願の目的化合物(ト)は、化合物(II)と化合物(
I)とを反応させることにより製造できる。
The target compound (g) of the present application consists of compound (II) and compound (
It can be produced by reacting with I).

この反応は、一般式(■)1モルに対し、(I)の過剰
モル量、一般に約1〜5モル量が好んで用いられる。
In this reaction, an excess molar amount of (I), generally about 1 to 5 molar amount, is preferably used with respect to 1 mole of general formula (■).

反応は通常反応自体に不活性の適宜の溶剤、たとえばア
ルコール類(例、メタノール、エタノール、プロパツー
ルなと)あるいはジアルキルホルムアミド類(例、ジメ
チルホルムアミド、ジエチルホルムアミドなど)などが
用いられるが、必ずしも溶剤の要はなく、直接両者を反
応させてもよい。
Usually, an appropriate inert solvent is used for the reaction itself, such as alcohols (e.g., methanol, ethanol, propatool, etc.) or dialkylformamides (e.g., dimethylformamide, diethylformamide, etc.). There is no need for this, and both may be reacted directly.

反応温度は00〜200℃の間の適宜の温度が選ばれる
As the reaction temperature, an appropriate temperature between 00 and 200°C is selected.

また、目的化合物(Vl)は、化合物(II)とヒドラ
ジノ酢酸エステル類(IV)を反応させて化合物(V)
を製造し、これにイソシアン酸を反応させることにより
製造することができる。
In addition, the target compound (Vl) can be obtained by reacting compound (II) with hydrazinoacetate (IV) to form compound (V).
It can be produced by producing and reacting this with isocyanic acid.

この反応に於いては、(■)1モルに対しGV)1〜5
モル使用し得るが、通常約1〜2モルが好んで用いられ
る。
In this reaction, (■) GV) 1 to 5 per mol
Although moles can be used, about 1 to 2 moles are usually preferred.

反応は反応自体に不活性の溶媒、たとえば(II)と(
1)の反応で記載した溶媒などが用いられるが、必ずし
も溶媒使用の必要はなく直接両者を反応させてもよい。
The reaction is carried out using a solvent that is inert to the reaction itself, such as (II) and (
Although the solvents described in reaction 1) are used, it is not always necessary to use a solvent and the two may be reacted directly.

反応温度は0°〜200°Cの間で適宜の温度を用いる
のが好ましい。
It is preferable to use an appropriate reaction temperature between 0° and 200°C.

このようにして製造した■)に、イソシアン酸を反応さ
せて化合物(VI)を製造する。
The compound (VI) thus produced is reacted with isocyanic acid to produce compound (VI).

この反応で用いられるイソシアン酸は一般式 %式%() 〔式中、Mはアルカリ金属(例、ナトリウム、カリウム
)またはアルカリ土類金属(例、カルシウム、バリウム
)を示し、Xは前記と同意義を有する〕で表わされる化
合物を酸性とすることにより生成するものであってもよ
い。
The isocyanic acid used in this reaction has the general formula % () [where M represents an alkali metal (e.g., sodium, potassium) or alkaline earth metal (e.g., calcium, barium), and X is the same as above. It may also be produced by acidifying a compound represented by [having a meaning].

通常■)と−を酸性条件で反応させるのが好ましく、そ
のために用いられる酸としてはたとえば酢酸あるいはプ
ロピオン酸のような有機酸、あるいは塩酸、硫酸のよう
な鉱酸等が繁用される。
Generally, it is preferable to react (1) and - under acidic conditions, and the acids used for this purpose include organic acids such as acetic acid or propionic acid, or mineral acids such as hydrochloric acid and sulfuric acid.

一般に(V)1モルに対しくVI[11〜10モルを用
いて反応させるのがよい。
Generally, it is preferable to carry out the reaction using 11 to 10 moles of VI per 1 mole of (V).

通常本反応は反応自体に不活性な溶媒、たとえば水、(
It)と(I)の反応で記載した溶媒等またはこれらの
混合物中で行なわれる。
This reaction is usually carried out using a solvent that is inert to the reaction itself, such as water (
It is carried out in the solvents and the like described for the reaction of It) and (I), or in a mixture thereof.

あるいはこれら溶媒と上記酸類の混合溶媒を用いること
もできるし、酸自体を溶媒とすることもできる。
Alternatively, a mixed solvent of these solvents and the above acids can be used, or the acid itself can be used as the solvent.

反応温度は通常200〜150℃の間の適宜の温度が選
ばれる。
The reaction temperature is usually selected to be an appropriate temperature between 200 and 150°C.

このようにして製造された(口)は、反応液を中性とす
ると通常結晶性物質として採取することができる。
The product thus produced can usually be collected as a crystalline substance when the reaction solution is neutralized.

本化合物(ト)は必要に応じて、たとえばクロマトグラ
フィー、再結晶法などそれ自体公知の精製手段により、
より高純変のものとすることもできるが、一般にそのま
ま次工程の原料としても使用できる。
The present compound (g) can be purified by purification means known per se, such as chromatography or recrystallization, as necessary.
Although it can be modified to a higher purity, it can generally be used as it is as a raw material for the next step.

かくして得られる化合物(ト)を加熱することにより化
合物(I)を製造することができる。
Compound (I) can be produced by heating the compound (g) thus obtained.

本反応は、(ト)を約30°C〜200°Cの間から選
ばれた適宜の温度に加熱することにより目的を達成でき
る。
The purpose of this reaction can be achieved by heating (g) to an appropriate temperature selected from about 30°C to 200°C.

この際溶媒は用いないか、または必要により反応自体に
不活性な溶媒、たとえばジアルキルホルムアミド類(例
、ジメチル−またはジエチル−ホルムアミド等)、ジア
ルキルスルホキシド(例、ジメチル−またはジエチル−
スルホキシドなど)などの中で行なうこともできる。
At this time, no solvent is used, or if necessary, a solvent inert to the reaction itself, such as dialkylformamides (e.g., dimethyl- or diethyl-formamide, etc.), dialkyl sulfoxides (e.g., dimethyl- or diethyl-formamide, etc.),
It can also be carried out in sulfoxide, etc.).

通常(VI)1モルに対し縮合剤1〜10モル程度の添
加が好結果をもたらす。
Usually, good results are obtained by adding about 1 to 10 moles of the condensing agent to 1 mole of (VI).

このようにして製造された(I)はそれ自体公知の分離
精製手段、たとえば再結晶法、クロマトグラフ法などに
より任意線区のものとして採取できる。
(I) produced in this manner can be collected in any range by separation and purification methods known per se, such as recrystallization and chromatography.

通常(II)からの通算収率は70%以上90%程庇で
ある。
The total yield from normal (II) is about 70% or more and about 90%.

実施例 1 ヒドラジノ酢酸エチル塩酸塩Q、928.9の水2ml
溶液にイソシアン酸カリウム0.53iを加えて溶解、
15分間放置し、N′−力ルバモイルヒドラジノ酢酸エ
チルの溶液とする、この溶液に4N−塩酸を加えPH2
〜3に調整し、ついでエタノール10m4P−ニトロフ
ェニルフルフラール0.434gを加え、10分間加熱
還流後水を加え析出結晶を沢取するとN−(5−(P−
ニトロフェニル)フルフリリデンアミノ〕−N−力ルバ
モイルグリシンエチルエステルの結晶が得られる。
Example 1 Ethyl hydrazinoacetate hydrochloride Q, 928.9 2 ml of water
Add 0.53i of potassium isocyanate to the solution and dissolve.
Leave to stand for 15 minutes to make a solution of ethyl N'-rubamoylhydrazinoacetate. Add 4N-hydrochloric acid to this solution and adjust the pH to 2.
3, then 10 m of ethanol, 0.434 g of P-nitrophenylfurfural was added, and after heating under reflux for 10 minutes, water was added to collect the precipitated crystals, and N-(5-(P-
Crystals of nitrophenylfurfurylideneamino]-N-rubamoylglycine ethyl ester are obtained.

収率97.2% 本島は含水ジメチルホルムアミドから
再結晶すると、融点234−236℃を示す黄色針状晶
が得られる。
Yield: 97.2% Motojima is recrystallized from hydrous dimethylformamide to give yellow needles with a melting point of 234-236°C.

元素分析 C16H14N406 計算値 C53,33,’H4,48,N 15.5
5実験値 C53,47,H4,39,N 15.53
実施例 2 (1) 5−(P−ニトロフェニル)フルフラール0
.44gのエタノール10m1液に、ヒドラジノ酢酸エ
チルエステル塩酸塩0.34gを加え数分間加熱して溶
液とし、しばらく室温に放置、これに飽和炭酸水素すI
−IJウム液を加え酢酸エチルで抽出する。
Elemental analysis C16H14N406 Calculated value C53,33,'H4,48,N 15.5
5 Experimental values C53, 47, H4, 39, N 15.53
Example 2 (1) 5-(P-nitrophenyl)furfural 0
.. Add 0.34 g of hydrazinoacetic acid ethyl ester hydrochloride to 44 g of 10 ml of ethanol, heat for several minutes to form a solution, leave at room temperature for a while, and add saturated hydrogen carbonate solution I.
- Add IJum solution and extract with ethyl acetate.

酢酸エチル層は水洗、乾燥(Na2SO4)後溶媒を留
去すると、N−(5−(p−ニトロフェニル)フルフリ
リデンアミノ〕グリ針エチルエステルの結晶が得られる
The ethyl acetate layer is washed with water, dried (Na2SO4), and the solvent is distilled off to obtain crystals of N-(5-(p-nitrophenyl)furfurylideneamino)glyneedle ethyl ester.

赤橙色針状晶、融点120−122℃。Red-orange needles, melting point 120-122°C.

(2)上記で製造したN −(5−(P−ニトロフェニ
ル)フルフリリデンアミノ〕グリシンエチルエステル0
.32.?の酢酸5ml液に、氷冷下イソシアン酸カリ
ウム0.48gを3回に分けて加えた後、10分間かき
混ぜてから水を加え析出結晶を済取する。
(2) N-(5-(P-nitrophenyl)furfurylideneamino)glycine ethyl ester produced above 0
.. 32. ? Add 0.48 g of potassium isocyanate to 5 ml of acetic acid solution under ice-cooling in three portions, stir for 10 minutes, and then add water to collect the precipitated crystals.

水、アセトンで順次洗浄、乾燥tルトN−(5−(P−
ニトロフェニル)フルフリリデンアミノ〕−N−カルバ
モイルグリシンエチルエステルの結晶が得られる。
Washed sequentially with water and acetone and dried.
Crystals of nitrophenylfurfurylideneamino]-N-carbamoylglycine ethyl ester are obtained.

融点233−236°C0Melting point 233-236°C0

Claims (1)

【特許請求の範囲】 1 一般式 (式中、R1はニトロ基を示す)で表わされる化合物と
一般式 NH2−N−CH,C00R2 X=C−NH2 (式中、R2は低級アルキル基を、Xは酸素原子を示す
)で表わされる化合物を反応させることを特徴とする、
一般式 (式中、I(1,R2,Xは前記と同意義を有する)で
表わされる化合物の製造法。 2 一般式 (式中、R1はニトロ基を示す)で表わされる化合物と
一般式 %式% (式中、R2は低級アルキル基を示す)で表わされるヒ
ドラジノ酢酸エステル類を反応させて一般式 (式中、R1、R2は前記と同意義を有する)で表わさ
れる化合物を製造し、これにイソシアン酸を反応させる
ことを特徴とする、一般式 (式中、R’ j R2は前記と同意義を有し、Xは酸
素原子を示す。 )で表わされる化合物の製造法。
[Scope of Claims] 1 A compound represented by the general formula (wherein R1 represents a nitro group) and a compound represented by the general formula NH2-N-CH, C00R2 X=C-NH2 (wherein R2 represents a lower alkyl group, X represents an oxygen atom)
A method for producing a compound represented by the general formula (wherein I (1, R2, and X have the same meanings as above)). 2. A compound represented by the general formula (wherein R1 represents a nitro group) and the general formula A compound represented by the general formula (in the formula, R1 and R2 have the same meanings as above) is produced by reacting hydrazinoacetic esters represented by the formula % (in the formula, R2 represents a lower alkyl group). A method for producing a compound represented by the general formula (wherein R' j R2 has the same meaning as above, and X represents an oxygen atom), which comprises reacting this with isocyanic acid.
JP56154483A 1981-09-28 1981-09-28 Method for producing furfural derivatives Expired JPS5852995B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP56154483A JPS5852995B2 (en) 1981-09-28 1981-09-28 Method for producing furfural derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56154483A JPS5852995B2 (en) 1981-09-28 1981-09-28 Method for producing furfural derivatives

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP1357873A Division JPS5544752B2 (en) 1973-02-01 1973-02-01

Publications (2)

Publication Number Publication Date
JPS57145873A JPS57145873A (en) 1982-09-09
JPS5852995B2 true JPS5852995B2 (en) 1983-11-26

Family

ID=15585225

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56154483A Expired JPS5852995B2 (en) 1981-09-28 1981-09-28 Method for producing furfural derivatives

Country Status (1)

Country Link
JP (1) JPS5852995B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW224974B (en) * 1991-07-02 1994-06-11 Hoffmann La Roche
AU6902096A (en) * 1995-09-15 1997-04-01 Pharmacia & Upjohn Company 5-amidomethyl alpha, beta-saturated and -unsaturated 3-aryl butyrolactone antibacterial agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5544752A (en) * 1978-09-25 1980-03-29 Nec Corp Manufacture of multilayer wiring type semiconductor

Also Published As

Publication number Publication date
JPS57145873A (en) 1982-09-09

Similar Documents

Publication Publication Date Title
JP2707936B2 (en) β-oxo-β-benzenepropanethioamide derivative
JPH06172281A (en) Production of hydrochlorides of n-acyl derivative and free acid of 5-aminolevulinic acid
KR920002295B1 (en) Method for preparing prolidinone derivative
EP0349902A2 (en) Processes for the preparation of morniflumate and analogous compounds
HU191824B (en) Process for producing new pyridine and pyrimidine derivatives utilizable as intermediares producing antiflogistic and immunkregulating compounds
HU198200B (en) Process for production of derivatives of quinoline carbonic acid
JPS5852995B2 (en) Method for producing furfural derivatives
HU196798B (en) Process for producing quinazoline-diones and pyridopyrimidine-dions
JPS6310955B2 (en)
JPH0144708B2 (en)
SU528878A3 (en) The method of obtaining (heteroarylmethyl) -deoxynormorphine or deoxynorcodeine derivatives, or their salts
JP2771257B2 (en) Preparation of imidazole derivatives
JP2831000B2 (en) (2-aminobenzoyl) acetic acid ester derivative
KR950009316B1 (en) Process for preparing pyrrolidinecarboxylic acid derivative
JP4061333B2 (en) 2- (Pyrazol-1-yl) pyridine derivatives
JPH01156942A (en) 4-oxo-4-(substituted phenyl) butenoyl- salicilate
US4156728A (en) 3-Substituted-2(1H)pyridone-6-carboxylic acids
JPH0737444B2 (en) 4-Benzyloxy-3-pyrroline, process for its production and use for the production of tetramic acid
JPH072776A (en) Angiotensin ii-antagonistic pyridine derivative
JPH0780812B2 (en) Azulene derivative thromboxane synthetase inhibitor and process for producing the same
JPS6324994B2 (en)
JP3221151B2 (en) Method for producing pyrrole derivatives
JP3332171B2 (en) Method for producing thieno [3,2-b] pyridine derivative
JPS6134424B2 (en)
JPS62116548A (en) Aminoketone derivative